Filing Details

Accession Number:
0000950170-25-004971
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-01-13 18:51:18
Reporting Period:
2025-01-09
Accepted Time:
2025-01-13 18:51:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1707502 Solid Biosciences Inc. SLDB Biological Products, (No Disgnostic Substances) (2836) 900943402
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1884056 Kevin Tan C/O Solid Biosciences Inc.
500 Rutherford Avenue, Third Floor
Charlestown MA 02129
Cfo & Treasurer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-01-09 11,250 $0.00 28,862 No 4 M Direct
Common Stock Disposition 2025-01-10 4,073 $3.89 24,789 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2025-01-09 11,250 $0.00 11,250 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
22,500 No 4 M Direct
Footnotes
  1. Restricted stock units convert to common stock on a one-for-one basis.
  2. Includes 4,152 and 4,152 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2024 and November 29, 2024, respectively.
  3. This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The sales do not represent a discretionary trade by Mr. Tan.
  4. The restricted stock units were granted on January 9, 2023 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.